What Are the Signs of a Sarcoidosis Flare-Up?
At a Glance
A sarcoidosis flare-up involves active, new inflammation causing distinctly worsening symptoms like severe shortness of breath, profound fatigue, fevers, or new skin and eye lesions. Unlike stable chronic symptoms, a flare-up requires medical evaluation to prevent organ damage.
In this answer
3 sections
Living with sarcoidosis often means navigating daily chronic symptoms, but a true flare-up (exacerbation) is different: it indicates active, new inflammation that requires your doctor’s attention. While a “bad day” might involve your usual level of lingering fatigue or stable shortness of breath, a flare-up typically brings a distinct worsening of your respiratory symptoms, the return of profound exhaustion, new skin lesions, or systemic signs like fever and night sweats [1][2]. Recognizing the difference empowers you to seek medical care when it is truly needed.
Chronic Symptoms vs. Active Flare-Ups
Because sarcoidosis can cause long-term structural changes or scarring in the body, many patients experience chronic symptoms even when the disease is not actively inflamed [1]. Chronic symptoms are generally stable day-to-day.
An exacerbation, or flare-up, means your immune system is actively forming new granulomas (tiny clumps of inflammatory cells) [2]. Because a flare-up can threaten organ function, your doctor will want to evaluate new symptoms to decide if your treatment plan needs adjusting [1][3].
Clinical Signs of a Flare-Up
A flare-up can manifest in the lungs (where sarcoidosis most commonly strikes) or throughout the rest of the body. Key clinical signs that you may be experiencing a flare include:
- Worsening respiratory symptoms: A noticeable increase in your cough or new, worsening dyspnea (shortness of breath) during activities that you could previously handle [1][4].
- Systemic symptoms: The return of profound, debilitating fatigue, accompanied by unexplained fevers, night sweats, or unintentional weight loss [1][2].
- Skin and joint changes: The appearance of new skin lesions (such as painful bumps on your shins, raised plaques, or changes in old scars) [5][6], or new, severe joint pain (polyarthritis) [7][8].
- Eye changes: Sarcoidosis frequently causes ocular inflammation (such as uveitis) [9]. New eye pain, severe redness, light sensitivity, or blurry vision are signs of a flare-up that require rapid medical evaluation to prevent irreversible vision loss.
⚠️ Warning: Seek Emergency Care
If you experience new neurological symptoms (like severe headaches, facial weakness, or numbness) [1][4] or cardiac symptoms (like irregular heartbeats, palpitations, chest pain, or fainting spells) [4][10], do not wait for a routine doctor’s appointment. These can indicate life-threatening complications and require immediate emergency medical evaluation.
How Doctors Confirm a Flare-Up
Because symptoms alone can be subjective, doctors rely on objective medical tests to confirm if your sarcoidosis is actively flaring [3].
Pulmonary Function Tests (PFTs)
Your doctor will likely order breathing tests to measure your lung capacity. A significant decline in your FVC (Forced Vital Capacity, the total amount of air you can exhale) or DLCO (how well oxygen moves from your lungs into your blood) is a primary objective marker of clinical deterioration and disease progression [11][12].
Advanced Imaging and Exams
Standard chest X-rays can sometimes miss new inflammation. To get a clearer picture, doctors use:
- Thoracic CT Scans: High-resolution scans can reveal new structural changes or worsening lymph node enlargement [13][14].
- FDG-PET/CT Scans: These highly sensitive scans highlight areas of active glucose metabolism (showing where inflamed cells are using extra energy), pinpointing exactly where active inflammation is occurring in the body [15][16].
- Ophthalmologic Exams: A specialized “slit-lamp” exam by an eye doctor is a standard tool to detect active sarcoidosis in the eyes, even if you haven’t noticed severe vision changes yet [9].
Blood Biomarkers
While blood tests cannot diagnose a flare-up on their own, doctors use them alongside your symptoms and imaging [3][17]. They may look for elevated inflammatory markers like sIL-2R (soluble interleukin-2 receptor) or chitotriosidase, which can indicate active disease [18][19]. Note that while ACE (angiotensin-converting enzyme) levels are often tested, modern research shows they are not always reliable for monitoring disease activity in everyone [20][21].
Actionable Tip: If you suspect a flare-up, keep a brief daily symptom diary tracking the frequency and severity of your symptoms for a few days. Sharing this with your doctor will help them quickly differentiate between normal daily symptom fluctuations and a true exacerbation.
Common questions in this guide
How can I tell the difference between chronic sarcoidosis and a flare-up?
What are the emergency warning signs of a sarcoidosis flare-up?
How do doctors confirm a sarcoidosis exacerbation?
What blood tests show active sarcoidosis inflammation?
When should I contact my doctor about a potential sarcoidosis flare-up?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How much of a decline in my FVC or DLCO (percentage-wise) from my baseline do you consider a 'significant' drop that indicates a flare-up?
- 2.What is your specific protocol if I suspect a flare-up between routine appointments, and who is the best person on your team to contact?
- 3.Are we currently tracking my sIL-2R or chitotriosidase levels in addition to ACE levels to monitor for active inflammation?
- 4.Given my specific sarcoidosis manifestations, what 'red flag' symptoms should prompt me to go straight to the emergency room rather than waiting for a standard appointment?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (21)
- 1
[Epidemiology and Clinical Presentation of Sarcoidosis].
Costabel U, Wessendorf TE, Bonella F
Klinische Monatsblatter fur Augenheilkunde 2017; (234(6)):790-795 doi:10.1055/s-0042-105569.
PMID: 27454307 - 2
Fatigue syndrome in sarcoidosis.
Górski W, Piotrowski WJ
Pneumonologia i alergologia polska 2016; (84(4)):244-50 doi:10.5603/PiAP.2016.0030.
PMID: 27435351 - 3
BTS Clinical Statement on pulmonary sarcoidosis.
Thillai M, Atkins CP, Crawshaw A, et al.
Thorax 2021; (76(1)):4-20 doi:10.1136/thoraxjnl-2019-214348.
PMID: 33268456 - 4
Cardiac sarcoidosis as an incidental finding: A case report.
Gabaldon-Perez A, Garcia-Blas S, Forner MJ, et al.
Heart & lung : the journal of critical care 2020; (49(6)):783-787 doi:10.1016/j.hrtlng.2020.09.009.
PMID: 32980628 - 5
Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial.
Redl A, Doberer K, Unterluggauer L, et al.
The Lancet. Rheumatology 2024; (6(2)):e81-e91 doi:10.1016/S2665-9913(23)00302-8.
PMID: 38267106 - 6
Extrapulmonary sarcoidosis in an atypical patient demographic.
Modi T, Maniam G, Quirch M, et al.
Proceedings (Baylor University. Medical Center) 2020; (34(1)):151-152 doi:10.1080/08998280.2020.1824963.
PMID: 33456182 - 7
Löfgren Syndrome: A Mosaic of Sarcoidosis Phenotypes.
Martins F, Martins M, Malheiro R
Cureus 2024; (16(1)):e52317 doi:10.7759/cureus.52317.
PMID: 38226315 - 8
[Musculoskeletal manifestations of sarcoidosis].
Korsten P, Chehab G
Zeitschrift fur Rheumatologie 2017; (76(5)):408-414 doi:10.1007/s00393-017-0313-5.
PMID: 28488045 - 9
Usefulness of Combined Measurement of Serum Soluble IL-2R and Angiotensin-Converting Enzyme in the Detection of Uveitis Associated with Japanese Sarcoidosis.
Ishihara M, Meguro A, Ishido M, et al.
Clinical ophthalmology (Auckland, N.Z.) 2020; (14()):2311-2317 doi:10.2147/OPTH.S264595.
PMID: 32848359 - 10
Cardiac Sarcoidosis: A Contemporary Concept of Forgotten Granulomatosis.
Avagimyan A, Mkrtchyan L, Bairamyan T, et al.
ARYA atherosclerosis 2023; (19(5)):52-62 doi:10.48305/arya.2023.41534.2888.
PMID: 38882645 - 11
Lymphocyte Subsets and Pulmonary Nodules to Predict the Progression of Sarcoidosis.
Danila E, Aleksonienė R, Besusparis J, et al.
Biomedicines 2023; (11(5)) doi:10.3390/biomedicines11051437.
PMID: 37239108 - 12
Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction?: A case-control study.
Martusewicz-Boros MM, Boros PW, Wiatr E, et al.
Medicine 2019; (98(47)):e18037 doi:10.1097/MD.0000000000018037.
PMID: 31764823 - 13
From X-rays to advanced imaging modalities in pulmonary sarcoidosis.
Ledda RE, Roberti C, Sverzellati N
Current opinion in immunology 2025; (98()):102709 doi:10.1016/j.coi.2025.102709.
PMID: 41406556 - 14
Relationship Between Thoracic CT Severity Score and Scadding Staging With PFT, DLCO, and 6MWT in Patients With Sarcoidosis.
Takeş MA, Korkmaz C, Poyraz N, et al.
Canadian respiratory journal 2025; (2025()):1655729 doi:10.1155/carj/1655729.
PMID: 41311681 - 15
Meta-analysis of [18F]FDG-PET/CT in pulmonary sarcoidosis.
Donnelly R, McDermott M, McManus G, et al.
European radiology 2025; (35(4)):2222-2232 doi:10.1007/s00330-024-10949-4.
PMID: 39044038 - 16
Systemic sarcoidosis with pituitary adenoma.
Carbone RG, Penna D, Monselise A, Puppo F
Journal of clinical imaging science 2022; (12()):32 doi:10.25259/JCIS_43_2022.
PMID: 35769093 - 17
Biomarkers in sarcoidosis.
Chopra A, Kalkanis A, Judson MA
Expert review of clinical immunology 2016; (12(11)):1191-1208 doi:10.1080/1744666X.2016.1196135.
PMID: 27253883 - 18
YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity.
Uysal P, Durmus S, Sozer V, et al.
Biomolecules 2018; (8(3)) doi:10.3390/biom8030084.
PMID: 30154391 - 19
Verifying Sarcoidosis Activity: Chitotriosidase versus ACE in Sarcoidosis - a Case-control Study.
Popević S, Šumarac Z, Jovanović D, et al.
Journal of medical biochemistry 2016; (35(4)):390-400 doi:10.1515/jomb-2016-0017.
PMID: 28670191 - 20
Put Down the ACE: Low Clinical Utility for Angiotensin-Converting Enzyme Levels in Sarcoidosis: A Single-Center Retrospective Cohort Study.
Druyan A, Shuv N, Lidar M
Journal of clinical medicine 2024; (13(24)) doi:10.3390/jcm13247657.
PMID: 39768579 - 21
Role of serum soluble interleukin 2-receptor in the evaluation of myocardial inflammation in patients with cardiac sarcoidosis and ventricular arrhythmias.
Reithmann C, Min S, Kling T, et al.
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2022; (65(2)):353-355 doi:10.1007/s10840-022-01271-4.
PMID: 35697889
This page explains the clinical signs of a sarcoidosis flare-up for educational purposes only and does not replace professional medical advice. Always contact your healthcare provider immediately if you experience severe or rapidly worsening symptoms.
Get notified when new evidence is published on Sarcoidosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.